DERIVATIVE FINANCIAL INSTRUMENTS

6 Months Ended

Aug. 02, 2020

Notes to Financial Statements [Abstract]

Cash Flow Hedges

The Company has exposure to changes in foreign currency exchange rates related to anticipated cash flows associated with certain international inventory purchases. The Company uses foreign currency forward exchange contracts to hedge against a portion of this exposure.

The Company also has exposure to interest rate volatility related to its term loans under the 2019 facilities. The Company has entered into interest rate swap agreements to hedge against a portion of this exposure. Please see Note 9, “Debt,” for further discussion of the 2019 facilities and these agreements.

The Company records the foreign currency forward exchange contracts and interest rate swap agreements at fair value in its Consolidated Balance Sheets and does not net the related assets and liabilities. The foreign currency forward exchange contracts associated with certain international inventory purchases and the interest rate swap agreements are designated as effective hedging instruments (collectively, “cash flow hedges”). The changes in the fair value of the cash flow hedges are recorded in equity as a component of accumulated other comprehensive loss (“AOCL”). No amounts were excluded from effectiveness testing. During the twenty-six weeks ended August 2, 2020, the Company dedesignated certain cash flow hedges due to the impacts of the COVID-19 pandemic, which resulted in the release of an immaterial gain from AOCL into the Company’s Consolidated Statements of Operations. The Company continues to believe that transactions relating to its other designated cash flow hedges are probable to occur as of August 2, 2020.

Net Investment Hedges

The Company has exposure to changes in foreign currency exchange rates related to the value of its investments in foreign subsidiaries denominated in a currency other than the United States dollar. To hedge against a portion of this exposure, the Company designated the carrying amounts of its (i) €600.0 million principal amount of 3 1/8% senior notes due 2027 and (ii) €525.0 million principal amount of 3 5/8% senior notes due 2024, of which €175.0 million principal amount was issued during the first quarter of 2020 (collectively, “foreign currency borrowings”), that were issued by PVH Corp., a U.S.-based entity, as net investment hedges of its investments in certain of its foreign subsidiaries that use the euro as their functional currency. Please see Note 9, “Debt,” for further discussion of the Company’s foreign currency borrowings.

The Company records the foreign currency borrowings at carrying value in its Consolidated Balance Sheets. The carrying value of the foreign currency borrowings is remeasured at the end of each reporting period to reflect changes in the foreign currency exchange spot rate. Since the foreign currency borrowings are designated as net investment hedges, such remeasurement is recorded in equity as a component of AOCL. The fair value and the carrying value of the foreign currency borrowings designated as net investment hedges were $1,320.3 million and $1,318.5 million, respectively, as of August 2, 2020, $1,178.6 million and $1,038.5 million, respectively, as of February 2, 2020 and $1,187.0 million and $1,042.6 million, respectively, as of

August 4, 2019. The Company evaluates the effectiveness of its net investment hedges at inception and at the beginning of each quarter thereafter. No amounts were excluded from effectiveness testing.

Undesignated Contracts

The Company records immediately in earnings changes in the fair value of hedges that are not designated as effective hedging instruments (“undesignated contracts”), including foreign currency forward exchange contracts related to third party and intercompany transactions, and intercompany loans that are not of a long-term investment nature. Any gains and losses that are immediately recognized in earnings on such contracts are largely offset by the remeasurement of the underlying balances.

The Company does not use derivative or non-derivative financial instruments for trading or speculative purposes. The cash flows from the Company’s hedges are presented in the same category in the Company’s Consolidated Statements of Cash Flows as the items being hedged.

The following table summarizes the fair value and presentation of the Company’s derivative financial instruments in its Consolidated Balance Sheets:


(In millions)	Assets																							Liabilities
	8/2/20						2/2/20						8/4/19					8/2/20						2/2/20		8/4/19
	Other Current Assets		Other Assets		Other Current Assets		Other Assets		Other Current Assets		Other Assets			Accrued Expenses		Other Liabilities		Accrued Expenses		Other Liabilities		Accrued Expenses		Other Liabilities
Contracts designated as cash flow hedges:
Foreign currency forward exchange contracts (inventory purchases)	$	3.0	$	—	$	21.4	$	0.4	$	36.0	$	0.7		$	23.4	$	0.2	$	1.2	$	0.1	$	1.6	$	0.1
Interest rate swap agreements	—		—		0.1		—		0.3		—			8.3		2.9		5.5		0.4		4.1		2.9
Total contracts designated as cash flow hedges	3.0		—		21.5		0.4		36.3		0.7			31.7		3.1		6.7		0.5		5.7		3.0
Undesignated contracts:
Foreign currency forward exchange contracts	2.8		—		1.5		—		3.8		—			6.4		—		0.9		—		2.2		—


Total	$	5.8	$	—	$	23.0	$	0.4	$	40.1	$	0.7		$	38.1	$	3.1	$	7.6	$	0.5	$	7.9	$	3.0

The notional amount outstanding of foreign currency forward exchange contracts was $1,002.0 million at August 2, 2020. Such contracts expire principally between August 2020 and November 2021.

The following tables summarize the effect of the Company’s hedges designated as cash flow and net investment hedging instruments:


	(Loss) Gain Recognized in Other Comprehensive Income (Loss)

(In millions)

Thirteen Weeks Ended	8/2/20		8/4/19
Foreign currency forward exchange contracts (inventory purchases)	$	(57.9)	$	12.4
Interest rate swap agreements	(0.6)		(4.0)
Foreign currency borrowings (net investment hedges)	(108.1)		4.6
Total	$	(166.6)	$	13.0

Twenty-Six Weeks Ended	8/2/20		8/4/19
Foreign currency forward exchange contracts (inventory purchases)	$	(36.1)	$	42.5
Interest rate swap agreements	(10.0)		(5.1)
Foreign currency borrowings (net investment hedges)	(92.9)		34.2
Total	$	(139.0)	$	71.6


	Amount of Gain (Loss) Reclassified from AOCL into Income (Expense), Consolidated Statements of Operations Location, and Total Amount of Consolidated Statements of Operations Line Item
(In millions)	Amount Reclassified					Location		Total Statements of Operations Amount

Thirteen Weeks Ended	8/2/20		8/4/19			8/2/20		8/4/19
Foreign currency forward exchange contracts (inventory purchases)	$	0.9	$	10.7	Cost of goods sold	$	697.4	$	1,075.8
Interest rate swap agreements	(2.9)		0.0		Interest expense	32.7		28.3
Total	$	(2.0)	$	10.7

Twenty-Six Weeks Ended	8/2/20		8/4/19			8/2/20		8/4/19
Foreign currency forward exchange contracts (inventory purchases)	$	3.1	$	25.7	Cost of goods sold	$	1,375.5	$	2,136.2
Interest rate swap agreements	(4.6)		0.2		Interest expense	55.2		59.3

Total	$	(1.5)	$	25.9

A net loss in AOCL on foreign currency forward exchange contracts at August 2, 2020 of $7.3 million is estimated to be reclassified in the next 12 months in the Company’s Consolidated Statement of Operations to cost of goods sold as the underlying inventory hedged by such forward exchange contracts is sold. In addition, a net loss in AOCL for interest rate swap agreements at August 2, 2020 of $8.3 million is estimated to be reclassified to interest expense within the next 12 months. Amounts recognized in AOCL for foreign currency borrowings would be recognized in earnings only upon the sale or substantially complete liquidation of the hedged net investment.

The following table summarizes the effect of the Company’s undesignated contracts recognized in SG&A expenses in its Consolidated Statements of Operations:


(In millions)	(Loss) Gain Recognized in (Expense) Income
Thirteen Weeks Ended	8/2/20		8/4/19

Foreign currency forward exchange contracts	$	(4.7)	$	0.8

Twenty-Six Weeks Ended	8/2/20		8/4/19
Foreign currency forward exchange contracts	$	(4.1)	$	0.7

The Company had no derivative financial instruments with credit risk-related contingent features underlying the related contracts as of August 2, 2020.